常用名 | LY3437943 | CAS号 | 2381089-83-2 |
---|---|---|---|
价格 | ¥需询单/1kg ¥需询单/1g ¥需询单/1mg ¥需询单/1ton | 纯度 | 99.0% |
备货期 | 1天 | 库存 | 现货 |
产品网页 | https://peptidee.com/index.php/product/retatrutide/ |
产品详情(用途,包装等)
Retatrutide Overview Retatrutide, with its compound code LY-3437943, is an experimental peptide drug targeting obesity. It functions as a triple hormone receptor agonist, influencing metabolic regulation and appetite control. Notably effective in weight reduction, it’s a pioneering approach in obesity management, offering potential improvements in metabolic health. Product Details Structure:Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg Molecular Formula:C101H152N28O22S2 Molecular Weight:64 g/mol PubChem SID:255386757 CAS Number:1627580-64-6 Synonyms:Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1 Research Highlights Retatrutide & Weight Loss:In a phase 2 trial, participants saw a mean weight reduction of 18% at 24 weeks and 24% at 48 weeks, surpassing placebo results. Retatrutide & Glucose Metabolism:As a triple agonist, it positively influences glucose metabolism, beneficial in managing obesity-related impaired glucose regulation. Retatrutide & Dose Response:The trial demonstrated a dose-response relationship, with higher doses leading to greater weight reduction, highlighting its customizable potential for obesity treatment. Important Notices: This product is sold for scientific research purposes only.
更多
|